ONCY News and Press, Oncolytics Biotech Inc. From 02/22/22

Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights Conference call and webcast to take place on Thursday, March 3, 2022, at 5:00 p.m. ET PR Newswire SAN DIEGO, Calif. and ...

Oncolytics Biotech (NASDAQ:ONCY) said no safety concerns were seen in the three-patient pancreatic cancer group of a phase 1/2 GOBLET study evaluating pelareorep in combination with Roche's (OTCQX:RHHBY) atezolizumab. Data Safety Monitoring Board recommended the study proceed as pla...

Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials offer patients early access to cutting-edge treatments that ...

Oncolytics Biotech® Provides Positive Safety Update on the Pancreatic Cancer Cohort of its Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial Canada NewsWire Independent safety review completed with no toxicity concerns Cohort builds on prior proof-o...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group –  There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types of cancer that are getting closer t...

Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018, breast cancer ranks as the fifth leading cause of deaths in...

Oncolytics Biotech® Partner Adlai Nortye Advances to the Second Dose Escalation Cohort of the Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer Canada NewsWire Enrollment in the first dose escalation is complete with no...

FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 24, 2022 – USA News Group –  Within the grand battle against cancer, the use of immunotherapy continues to grow at incredible rates. According to Precedence Researc...

FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 20, 2021 – USA News Group –  As the 2021 San Antonio Breast Cancer Symposium (SABCS) comes to a close, many of this year’s presenters provided very encourag...

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer, across the world. The high mortality rates are pr...